HSR21-051: Treatment Outcomes Among HR+/HER2- Advanced/Metastatic Breast Cancer Patients Receiving CDK 4 & 6 Inhibitors in a United States Clinical Practice Setting

Clinical Practice ◽

Treatment Outcomes ◽

Cancer Patients ◽

Metastatic Breast ◽

Practice Setting ◽

Breast Cancer Patients ◽

Clinical Practice Setting

116P Real-world treatment patterns and clinical effectiveness of eribulin in HR+/HER2- metastatic breast cancer patients in the United States

Annals of Oncology ◽

10.1016/j.annonc.2021.03.130 ◽

2021 ◽

Vol 32 ◽

pp. S72

Author(s):

S.S. Mougalian ◽

J. Zhang ◽

J.K. Kish ◽

M.E. Zettler ◽

B.A. Feinberg

Keyword(s):

Breast Cancer ◽

United States ◽

Cancer Patients ◽

Real World ◽

Metastatic Breast ◽

Clinical Effectiveness ◽

The United States ◽

Treatment Patterns ◽

PCN28 Budget Impact Analysis of Everolimus for ER+, HER2- Metastatic Breast Cancer Patients in the United States

Value in Health ◽

10.1016/j.jval.2012.03.1145 ◽

2012 ◽

Vol 15 (4) ◽

pp. A212

Author(s):

J. Xie ◽

M. Diener ◽

G. De ◽

E.Q. Wu ◽

M. Namjoshi

Keyword(s):

Breast Cancer ◽

United States ◽

Cancer Patients ◽

Impact Analysis ◽

Budget Impact ◽

Metastatic Breast ◽

The United States ◽

Budget Impact Analysis ◽

Abstract P2-13-03: Prevalence of non-metastatic breast cancer patients treated with aromatase inhibitors in the United States

10.1158/0008-5472.sabcs12-p2-13-03 ◽

2012 ◽

Cited By ~ 1

Author(s):

A Liede ◽

RK Hernandez ◽

M Pirolli ◽

J Quigley ◽

D Quach

Keyword(s):

Breast Cancer ◽

United States ◽

Cancer Patients ◽

Aromatase Inhibitors ◽

Metastatic Breast ◽

The United States ◽

316P Real-world treatment patterns and clinical effectiveness outcomes of eribulin in metastatic breast cancer patients in community oncology centers in the United States

Annals of Oncology ◽

10.1016/j.annonc.2020.08.418 ◽

2020 ◽

Vol 31 ◽

pp. S369

Author(s):

S.S. Mougalian ◽

J.K. Kish ◽

J. Zhang ◽

T. Miller ◽

D. Liassou ◽

...

Keyword(s):

Breast Cancer ◽

United States ◽

Cancer Patients ◽

Metastatic Breast ◽

Clinical Effectiveness ◽

The United States ◽

Treatment Patterns ◽

Breast Cancer Patients ◽

Community Oncology

CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-5027-0 ◽

2018 ◽

Vol 173 (3) ◽

pp. 521-532 ◽

Cited By ~ 11

Author(s):

Britt I. Drögemöller ◽

◽

Galen E. B. Wright ◽

Joanne Shih ◽

Jose G. Monzon ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Clinical Practice ◽

Cancer Patients ◽

Decision Aid ◽

Metastatic Breast ◽

Treatment Decision ◽

Breast Cancer Patients ◽

Er Positive

HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes

Drugs - Real World Outcomes ◽

10.1007/s40801-016-0102-5 ◽

2017 ◽

Vol 4 (1) ◽

pp. 1-7 ◽

Cited By ~ 11

Author(s):

Nicholas J. Robert ◽

Hans-Peter Goertz ◽

Pooja Chopra ◽

Xiaolong Jiao ◽

Bongin Yoo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Treatment Patterns ◽

Practice Setting ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Community Oncology ◽

Oncology Practice

243P CDK4/6 inhibitors in clinical practice during COVID-19 pandemic: Comparative analysis of the clinical impact of the pandemic for metastatic breast cancer patients during first and second waves in the UK

Annals of Oncology ◽

10.1016/j.annonc.2021.08.526 ◽

2021 ◽

Vol 32 ◽

pp. S465

Author(s):

M.M. Fouda ◽

V. Kuriakose

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Comparative Analysis ◽

Cancer Patients ◽

Metastatic Breast ◽

Clinical Impact ◽

Breast Cancer Patients ◽

The Uk

Abstract PS6-46: Correlation of Tumor-infiltrating lymphocytes with clinicopathological features and treatment outcomes in non-metastatic breast cancer patients

10.1158/1538-7445.sabcs20-ps6-46 ◽

2021 ◽

Author(s):

Neamat Elsayed Hegazy ◽

Haitham Mohsen Abdel Motal ◽

Hanan Yehia Tayel ◽

Abdelsalam A Ismail

Keyword(s):

Breast Cancer ◽

Treatment Outcomes ◽

Cancer Patients ◽

Metastatic Breast ◽

Tumor Infiltrating Lymphocytes ◽

Clinicopathological Features ◽

Breast Cancer Patients ◽

Infiltrating Lymphocytes

Treatment after Progression on Fulvestrant among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study

Scientific Reports ◽

10.1038/s41598-018-37472-z ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 1

Author(s):

Yizhao Xie ◽

Yannan Zhao ◽

Chengcheng Gong ◽

Zhanhong Chen ◽

Yinbin Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Practice ◽

Retrospective Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Comparison of clinical characteristics and survival of metastatic breast cancer patients in United States according to insurance status as compared to outcomes in Canada.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e18617 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e18617-e18617

Author(s):

Adriana Reis Brandao Matutino ◽

Allan Andresson Lima Pereira ◽

Elizabeth Kornaga ◽

Sasha M. Lupichuk ◽

Sunil Verma

Keyword(s):

Breast Cancer ◽

United States ◽

Cancer Patients ◽

Clinical Characteristics ◽

Metastatic Breast ◽

Insurance Status ◽